Indian pharmaceutical industry
Domestic generic producers may see near-term gains as US imposes tariffs on pharma
Indian pharma companies’ revenue to grow 7-9 pc in FY26 amidst US market risks: Report
Rifampicin drug used in TB treatment is expected to be commissioned later this year
Indian CRDMO sector set to touch USD 22-25 billion by 2035: Report